PROMETHEUS semi-finalist in XPRIZE Healthspan

Event

PROMETHEUS semi-finalist in XPRIZE Healthspan

Singapore · Research

Type
Research
Market
Singapore
When
May 2025

What to watch

Why variis flagged this

NUS Academy PROMETHEUS trial awarded Milestone 1 semi-finalist in XPRIZE Healthspan.

Common questions

PROMETHEUS semi-finalist in XPRIZE Healthspan: what happened?
NUS Academy PROMETHEUS trial awarded Milestone 1 semi-finalist in XPRIZE Healthspan.
PROMETHEUS semi-finalist in XPRIZE Healthspan: when?
May 2025. variis records dates only to the precision the source published, so a date given here as a month or a year is not being rounded from something more exact.
PROMETHEUS semi-finalist in XPRIZE Healthspan: who is involved?
NUS Academy for Healthy Longevity
PROMETHEUS semi-finalist in XPRIZE Healthspan: why does variis track it?
It is recorded as research in Singapore, one of the categories variis follows across the longevity market.

Keep reading

Related coverage from the newsroom.

Lecture hall session at NUS's Intensive Course on Healthy Longevity launched alongside its new Healthy Longevity Graduate Certificate Singapore.

Singapore · Industry

NUS launches healthy longevity graduate certificate

Morrow's founder Allen Law, argue that longevity care can move beyond elite clinics through lifestyle medicine and AI-powered approaches.

Singapore · Industry

Can longevity be designed for everyone, not just the wealthy?

Prof. Andrea B. Maier in a research laboratory at NUS, Co-Founder of the NUS Academy for Healthy Longevity, advancing Singapore's healthy longevity research.

Singapore · Industry

Singapore pushes clinical longevity care into the mainstream

Suggest an update

Every entity profile on variis is sourced. Not medical or investment advice.